Company news
2021-08-17
Today, we Bioperfectus solemnly announce that our products have been authorized by SFDA(Saudi Food and Drug Authority).
It also remarks another milestone and recognition of our products in the international market.
Learn more about our products' authorization on SFDA website BY CLICKING HERE.
Tick-borne diseases pose a substantial burden on global health, necessitating urgent attention. Addressing the challenge of tick-borne illnesses is crucial for ensuring the protection of public health worldwide.
Today, we spotlight the remarkable journey of BioPerfectus's global footprint, a testament to our significant growth and expansion.
BioPerfectus announces the CE marking of one new product: Herpes Simplex Virus Type I/II Real Time PCR Kit.
Copyright © 2010-2022 Jiangsu Bioperfectus Technologies Co., Ltd All Rights Reserved.
Tel: +86 021-5484 7326 Email: info@bioperfectus.com
